Bangkok Genomics Innovation PCL (BKK:BKGI) ROE % Adjusted to Book Value: 14.19% (As of Dec. 2025)


BKK:BKGI Bangkok Genomics Innovation PCL BKK:BKGI
45 GF Score
Price ฿2.12
! 12 Warning Signs
View Full Analysis

What is Bangkok Genomics Innovation PCL ROE % Adjusted to Book Value?

Bangkok Genomics Innovation PCL BKK:BKGI -0.93% 45 ROE % Adjusted to Book Value is 14.19% as of Dec. 2025. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review.

Bangkok Genomics Innovation PCL's ROE % for the quarter that ended in Dec. 2025 was 19.30%. Bangkok Genomics Innovation PCL's PB Ratio for the quarter that ended in Dec. 2025 was 1.36. Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 14.19%.

Bangkok Genomics Innovation PCL ROE % Adjusted to Book Value Related Terms

Bangkok Genomics Innovation PCL ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bangkok Genomics Innovation PCL ROE % Adjusted to Book Value Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial 0.00 0.00 0.00 5.28 6.13

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.77 2.79 2.24 2.94 14.19

BKK:BKGI vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bangkok Genomics Innovation PCL ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value falls into.


BKK:BKGI
45GF Score
Bangkok Genomics Innovation PCL BKK:BKGI
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bangkok Genomics Innovation PCL ROE % Adjusted to Book Value Calculation

Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.33% / 1.36
=6.13%

Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=19.30% / 1.36
=14.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 14.19% mean?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a ROE % Adjusted to Book Value of 14.19% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bangkok Genomics Innovation PCL and its competitors.
Is Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value too high?
Bangkok Genomics Innovation PCL's current ROE % Adjusted to Book Value is 14.19%. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value compare to TMO and DHR?
Bangkok Genomics Innovation PCL's ROE % Adjusted to Book Value of 14.19% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Bangkok Genomics Innovation PCL and its competitors. Bangkok Genomics Innovation PCL's current ROE % Adjusted to Book Value is 14.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current ROE % Adjusted to Book Value of 14.19%. The current ROE % Adjusted to Book Value is 14.19%. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current ROE % Adjusted to Book Value is 14.19% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bangkok Genomics Innovation PCL Business Description

Address 3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score

Get the complete analysis for BKK:BKGI

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿2.12
Price